Related Experiment Video
Updated: Oct 6, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel
Claudia Miranda1, Alejandro Ruiz-Picazo2, Paula Pomares2
1Unit of Modeling & Experimental Biopharmaceutics, Central "Marta Abreu" de Las Villas, Centro de Bioactivos Químicos Universidad, Santa Clara 50100, Cuba.
Abstract:
The main aim of this work is the biopharmaceutical characterization of a new hybrid benzodiazepine-dihydropyridine derivative, JM-20, derived with potent anti-ischemic and neuroprotective effects. In this study, the pKa and the pH-solubility profile were experimentally determined. Additionally, effective intestinal permeability was measured using three in vitro epithelial cell lines (MDCK, MDCK-MDR1 and Caco-2) and an in situ closed-loop intestinal perfusion technique. The results indicate that JM-20 is more soluble at acidic pH (9.18 ± 0.16); however, the Dose number (Do) was greater than 1, suggesting that it is a low-solubility compound. The permeability values obtained with in vitro cell lines as well as with the in situ perfusion method show that JM-20 is a highly permeable compound (Caco-2 value 3.8 × 10-5). The presence of an absorption carrier-mediated transport mechanism was also demonstrated, as well as the efflux effect of P-glycoprotein on the permeability values. Finally, JM-20 was provisionally classified as class 2 according to the biopharmaceutical classification system (BCS) due to its high intestinal permeability and low solubility. The potential good oral absorption of this compound could be limited by its solubility.
More Related Videos
08:23Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
Published on: August 9, 2014
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
In Vitro Drug Release Testing: Overview, Development and Validation
Preclinical Development: Overview
Drug Discovery: Overview
Drug Product Performance: In Vitro–In Vivo Correlation
In Vitro Drug Dissolution: Alternative Methods
In Vitro Drug Dissolution: Compendial Testing Models I